48,99 €
inkl. MwSt.
Versandkostenfrei*
Versandfertig in 1-2 Wochen
payback
24 °P sammeln
  • Broschiertes Buch

My book entitled Chemoenzymatic synthesis of biologically active entities, synthesis of both the stereoisomers of dihydrokawain-5-ol and development of novel synthetic methodologies . This has been divided into four chapters. Chapter-I is Biotransformations Introduction and Background Information. Chapter-II to IV are Chemoenzymatic synthesis of enantiomerically enriched Umbelactones, (R)-GABOB and (R)-Carnitine, (-)-Centrolobine, (R) and (S) enantiomers of Timolol, Kawalactones. This also include enantioselective total synthesis of both the stereoisomers of Dihydrokawain-5-ol and Cu(BF4)2…mehr

Produktbeschreibung
My book entitled Chemoenzymatic synthesis of biologically active entities, synthesis of both the stereoisomers of dihydrokawain-5-ol and development of novel synthetic methodologies . This has been divided into four chapters. Chapter-I is Biotransformations Introduction and Background Information. Chapter-II to IV are Chemoenzymatic synthesis of enantiomerically enriched Umbelactones, (R)-GABOB and (R)-Carnitine, (-)-Centrolobine, (R) and (S) enantiomers of Timolol, Kawalactones. This also include enantioselective total synthesis of both the stereoisomers of Dihydrokawain-5-ol and Cu(BF4)2 xH2O catalyzed one-pot synthesis of 'Biginelli' and 'Strecker' reactions.
Hinweis: Dieser Artikel kann nur an eine deutsche Lieferadresse ausgeliefert werden.
Autorenporträt
Dr. Krishnaji Tadiparthi was born in Eluru, INDIA. He obtained his PhD in Organic Chemistry (Biocatalysis) in 2008 from IICT, Hyderabad. He worked as a Post Doctoral Fellow at Freie University Berlin and University of Versailles. He is the author of several articles. Since 2010 he has been working as a Scientist at AstraZeneca, Bangalore.